UCSF

Tagged: mass spectrometry

QBI pioneers a collaborative and inclusive approach to scientific discovery

Tue Oct 16, 2018
Krogan, PhD, director of QBI
Credit: 
Chris Goodfellow/Gladstone Institutes

Nevan Krogan, PhD, founded QBI two years ago aiming to build a thriving scientific community at UCSF.

UCSF’s Quantitative Biosciences Institute (QBI), founded two years ago, is making waves with its unique approach to scientific collaboration, catalyzing discoveries from cancer to psychiatry while supporting female scientists and engaging with the public.

A pop-up repair shop for damaged neurons

Wed Apr 4, 2018
Burlingame
Credit: 
majedphoto.com

Alma Burlingame, PhD, is a faculty member in the UCSF School of Pharmacy and director of the UCSF Mass Spectrometry Facility.

Collaborative research holds promise for harnessing the nervous system’s own repair programs.

Taking a bite out of the proteome with PhaNGS

Wed Mar 7, 2018
If DNA is the blueprint for every cell in the body, then proteins are the cell’s construction workers, forklifts, and building materials.

Unmasking a cellular hallmark of cancer

Mon Jan 29, 2018
Wells
Credit: 
Elisabeth Fall

James Wells, PhD, lead author on paper

Scientists identify a signature of cancers caused by mutant RAS that may lead to precise therapies.

Research: Elusive drug targets; cell demolition enzymes; useful pharmacogenomics info

Thu May 5, 2016

Predicting difficult-to-detect drug binding sites

Craik receives Protein Society’s Emil Thomas Kaiser Award

Fri Mar 11, 2016
Craik
Credit: 
© majedphoto.com

Charles S. Craik, PhD

Charles S. Craik, PhD, faculty member in the School’s Department of Pharmaceutical Chemistry, has been named the 2016 recipient of the Protein Society’s Emil Thomas Kaiser Award.

Burlingame and Gross labs shed light on braking mechanisms in cellular signaling

Wed Jun 11, 2014
Burlingame and Gross
Credit: 
© majedphoto.com

Al Burlingame, PhD (left) and John Gross, PhD

How do cells that must respond rapidly and robustly to changes in the environment subsequently modulate that response so such elevated activity doesn’t prove harmful? Put another way: How do cells put the brakes on their response to external signaling in order to re-stabilize themselves?

Al Burlingame, PhD

Burlingame
Professor

My research interests focus on the development of state of the art methodologies in mass spectrometry for use in advancing our global knowledge of human biology, specifically the dynamic, epigenetic modulation and regulation of the proteome.

Artificial kidney project led by Shuvo Roy cited at White House panel

Tue May 1, 2012
The Front of the White House
Credit: 
Ben | Smith on Flickr

The Front of the White House

Speaking on a White House panel discussing President Obama's just-released Bioeconomy Blueprint, UCSF Vice Chancellor for Research Keith Yamamoto, PhD, cited the implantable bioartificial kidney project led by UCSF bioengineer Shuvo Roy, PhD

Celebrating Al Burlingame’s contributions to mass spectrometry

Thu Apr 26, 2012
Al Burlingame, PhD
Credit: 
© majedphoto.com

Al Burlingame, PhD

From the start of his illustrious half-century career in mass spectrometry, Al Burlingame, PhD, has been part of a scientific sea change.

Pages

Make a gift
We see a time when precise therapeutics—used safely and effectively—improve the health of people everywhere.
© 2002–2019 The Regents of the University of California